HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.

Abstract
Overexpression of the immunosuppressive cytokine transforming growth factor beta (TGF-beta) is one strategy that tumors have developed to evade effective immunesurveillance. Using transplantable models of breast and colon cancer, we made the unexpected finding that CD8+ cells in tumor-bearing animals can directly promote tumorigenesis, by a mechanism that is dependent on TGF-beta. We showed that CD8+ splenocytes from tumor-bearing mice expressed elevated interleukin (IL)-17 when compared with naive mice, and that CD8+ T cells could be induced to make IL-17 on addition of TGF-beta and IL-6 in vitro. Treatment of mice with anti-TGF-beta antibodies in vivo reduced IL-17 expression both in the tumor and the locoregional lymph nodes. Although IL-17 has not previously been shown to act as a survival factor for epithelial cells, we found that IL-17 suppressed apoptosis of several tumor cell lines in vitro, suggesting that this altered T-cell polarization has the potential to promote tumorigenesis directly, rather than indirectly through inflammatory sequelae. Consistent with this hypothesis, knockdown of the IL-17 receptor in 4T1 mouse mammary cancer cells enhanced apoptosis and decreased tumor growth in vivo. Thus, in addition to suppressing immune surveillance, tumor-induced TGF-beta may actively subvert the CD8+ arm of the immune system into directly promoting tumor growth by an IL-17-dependent mechanism.
AuthorsJeong-Seok Nam, Masaki Terabe, Mi-Jin Kang, Helen Chae, Nga Voong, Yu-An Yang, Arian Laurence, Aleksandra Michalowska, Mizuko Mamura, Scott Lonning, Jay A Berzofsky, Lalage M Wakefield
JournalCancer research (Cancer Res) Vol. 68 Issue 10 Pg. 3915-23 (May 15 2008) ISSN: 1538-7445 [Electronic] United States
PMID18483277 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Interleukin-17
  • Transforming Growth Factor beta
Topics
  • Animals
  • CD4-Positive T-Lymphocytes (metabolism)
  • CD8-Positive T-Lymphocytes (metabolism)
  • Cell Line, Tumor
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Interleukin-17 (physiology)
  • Lymph Nodes (pathology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Transplantation
  • Neoplasms (immunology, metabolism)
  • Rats
  • Transforming Growth Factor beta (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: